Funding National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01 (NIH grant #R01DK119254) Pilot & Feasibility seed grant from the Stanford Diabetes Research Center (NIH grant #P30DK116074) Author contributions Conceptualization: AID, EAA Methodology: AID, CLM, LTN, EAA Investigation: AID, CLM, LTN, KL, ANP, IAH, SWB, CMK, CKJ, JY Visualization: AID, CLM, LTN Funding acquisition: EAA Project administration: EAA Supervision: EAA Writing original draft: AID, EAA Writing review & editing: CLM, LTN, KL, ANP, IAH, SWB, CMK, CKJ, JY, LH, DBS, HBR, EAA Competing interests E.A.A
Available from: European Medicines Agency (EMA) (2023) Suliqua
Find articles by Kirsop, J
It is for this reason that the latter is not routinely available on the NHS and hydroxocobalamin is the preferred treatment